CSF3 promotes colorectal cancer progression by activating p65/NF-κB signaling pathway and inducing an immunosuppressive microenvironment
Translational Oncology · 2025-03 · 53 · 102310
DOI: 10.1016/j.tranon.2025.102310 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Oncology, 2025-03. Verfasst von Junfeng Xu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Senior Department of Gastroenterology, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, PR China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Colony-stimulating factor 3 (CSF3) is a cytokine that promotes inflammation by stimulating the maturation, proliferation, and trafficking of myeloid progenitor cells. However, the functional importance of CSF3 in colorectal cancer (CRC) remains unclear. METHODS: CSF3 expression levels in CRC cells and tissues were detected by quantitative real-time PCR (qRT-PCR), western blot and immunohistochemistry (IHC). In vitro and in vivo assays were performed to investigate the oncogenic function of CSF3 in the tumor associated malignant phenotypes and the tumorigenic capability of CRC cells. Immunocoprecipitation was performed to verify the regulatory effects of CSF3 on IκBα ubiquitination. RESULTS: We found that CSF3 was overexpressed in CRC tissues compared to adjacent normal tissues, which correlated with poor patient survival. In vitro, silencing CSF3 significantly impaired cell proliferation, colony formation, and migration, while enhancing apoptosis. In vivo, silencing CSF3 resulted in reduced tumor growth, weight, and volume, indicating its potential as a therapeutic target. Mechanistically, CSF3 was found to mediate CRC development by activating the NF-κB signaling pathway, as evidenced by the decreased phosphorylation of p65 and reduced IκBα ubiquitination in CSF3-silenced cells. Furthermore, CSF3 silencing modulated immune infiltration in CRC, promoting an anti-tumor immune response and altering the tumor microenvironment. CONCLUSION: CSF3 modulated the NF-κB signaling pathway through a distinct mechanism involving p65 phosphorylation and the activation of NF-κB by enhancing IκBα ubiquitination, thereby effectively promoting CRC development, and CSF3 may serve as a potential therapeutic target for repressing CRC advance and metastasis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Senior Department of Gastroenterology, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, PR China.
- Senior Department of Gastroenterology, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, PR China; Department of Gastroenterology, The Seventh Medical Center of Chinese PLA General Hospital, Beij…
- Department of Gastroenterology, The Seventh Medical Center of Chinese PLA General Hospital, Beijing, 100700, PR China.
- Medical School of Chinese PLA, Beijing 100853, PR China.
- Cancer Research Center, Beijing Chest Hospital, Capital Medical University, Beijing 101149, PR China.
- Department of Gastroenterology, The Seventh Medical Center of Chinese PLA General Hospital, Beijing, 100700, PR China. Electronic address: wangxin1@301hospital.com.cn.
Förderung
- Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park
- National Natural Science Foundation of China
Zitieren
APA
Xu, J., Li, N., Xie, H., Duan, C., Liao, X., Li, R., Zhang, H., Pan, Y., Ma, X., Du, S., Sheng, J., Wang, X., Yang, L., & Jin, P. (2025). CSF3 promotes colorectal cancer progression by activating p65/NF-κB signaling pathway and inducing an immunosuppressive microenvironment. Translational Oncology, 53, 102310. https://doi.org/10.1016/j.tranon.2025.102310
Vancouver
Xu J, Li N, Xie H, Duan C, Liao X, Li R, et al. CSF3 promotes colorectal cancer progression by activating p65/NF-κB signaling pathway and inducing an immunosuppressive microenvironment. Translational Oncology. 2025;53:102310. doi:10.1016/j.tranon.2025.102310
BibTeX
@article{Xu2025,
author = {Xu, Junfeng and Li, Na and Xie, Hui and Duan, Changwei and Liao, Xingchen and Li, Ruoran and Zhang, Heng and Pan, Yuanming and Ma, Xianzong and Du, Shuwen and Sheng, Jianqiu and Wang, Xin and Yang, Lang and Jin, Peng},
title = {CSF3 promotes colorectal cancer progression by activating p65/NF-κB signaling pathway and inducing an immunosuppressive microenvironment},
journal = {Translational Oncology},
year = {2025},
volume = {53},
pages = {102310},
doi = {10.1016/j.tranon.2025.102310}
}
EUVIMED